ANIX

Anixa Biosciences Inc.

Price

$3.58

return (12m)

18.77%

p/e

-12.16

p/bv

9.31

DIVIDEND YIELD

0.00%

ANIX price

Anixa Biosciences

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ANIX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

2.73%

3 months

32.41%

1 year

18.77%

2 years

8.66%

5 years

-34.76%

10 years

-11.95%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ANIX

Valuation

P/E

-12.16

Sector -4.26

Industry -4.26

P/BV

9.31

Sector 2.11

Industry 2.11

P/Revenue (PSR)

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

8.28

Sector 1.25

Industry 1.25

P/Net Current Assets

9.43

Sector -5.47

Industry -5.47

P/Working Capital

9.33

Sector -1.10

Industry -1.10

EPS

-0.30

Sector -1.94

Industry -1.94

BVPS

0.39

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

0.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

0.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

0.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-76.55%

Sector -61.50%

Industry -61.50%

ROA

-68.06%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

9.79

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.89

Sector 0.43

Industry 0.43

Liabilities/Assets

0.11

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

-5.07%

Sector -

Industry -

Fundamentals ANIX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ANIX Anixa Biosciences Inc.	$3.58	21.19%	0.00%	-12.16	9.31	-76.55%	0.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ANIX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Anixa Biosciences

Anixa Biosciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

44 years

Founded: 1982

1989

Time since IPO - 37 years

5

Employees

Anixa Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $123.08 million, with shareholders equity totaling $13.22 million.

The company employs approximately 5 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Anixa Biosciences Inc. reported $- in revenue, generating net income of $-10.12 million.

Key financial metrics include a P/E ratio of -12.16, a price-to-book (P/B) ratio of 9.31, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ANIX.

Market cap

$123.08 million

Net worth

$13.22 million

$13,220,000.00

Assets

$14.87 million

$14,870,000.00

Total Shares Outstanding

34.00 million

34,000,000

Average Daily Trading Volume

Sector

Health Care

Industry

Biotechnology

ANIX

ANIX revenue and profits

Financial Results ANIX

DRAG THE FRAME TO SEE MORE DATA

ANIX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Anixa Biosciences (ANIX) today?

A cotação de Anixa Biosciences (ANIX) hoje está em US$ 3.58, com uma variação de 18.77% em relação ao último ano. A cotação de Anixa Biosciences (ANIX) iniciou o ano negociando na casa dos US$ 3.12 e hoje está em US$ 3.58. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Anixa Biosciences (ANIX) e dados de ações do Ibovespa e mercados internacionais.

Quando Anixa Biosciences (ANIX) paga dividendos?

Anixa Biosciences (ANIX) não distribuiu dividendos no último ano.

Is Anixa Biosciences (ANIX) a good investment?

Atualmente, Anixa Biosciences (ANIX) está cotada a US$ 3.58, com um P/L de -12.16, representando um desvio de -1,163% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 18.77 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 18.77%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Anixa Biosciences (ANIX) stock?

Investir em ações de Anixa Biosciences (ANIX) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Anixa Biosciences (ANIX) yield today?

A rentabilidade de Anixa Biosciences (ANIX) foi de 2.73% no último mês, 18.77% no último ano e -34.76% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Anixa Biosciences (ANIX) hoje, o investimento total seria de US$ 357.50, com base na cotação atual de US$ 3.58.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 424.60
Em 5 anos: US$ 233.23
Em 10 anos: US$ 314.78

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ANIX

Anixa Biosciences Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ANIX

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ANIX WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Anixa Biosciences

Anixa Biosciences Inc.

United States

44 years

1989

5

PROFIT X PRICE ANIX

Financial Results ANIX

ANIX cash flow

Asset, Revenue and Profit Growth - ANIX

ANIX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions